EW vs PRIM · P/E 47, rev $1.39B vs P/E 22, rev $1.74B
Edwards Lifesciences Corp (EW) versus Primoris Services Corporation (PRIM) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Primoris Services Corporation (PRIM) is a engineering & construction company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PRIM revenue for 2024-12-31 was $1.74B. Net income was $180.9M. Revenue was up 5.6% from 2024-09-30 to 2024-12-31. PRIM currently screens at market cap $5.52B and trailing P/E 22.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRIM currently screens at market cap $5.52B and trailing P/E 22.4.
Not investment advice. Open the EW and PRIM stock pages for the full models.
Not investment advice.